The movement to the downside is still in force and should gain in strength over the next trading sessions based on our expectations. Investors should open a short trade and target the € 29.
In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
For a short-term investment strategy, the company has poor fundamentals.
Graphically speaking, the timing seems perfect for purchasing the stock close to the EUR 30.37 support.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
The group usually releases upbeat results with huge surprise rates.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company is one of the best yield companies with high dividend expectations.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
According to Thomson-Reuters' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
One of the major weak points of the company is its financial situation.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The company's "enterprise value to sales" ratio is among the highest in the world.
The underlying tendency is negative on the weekly chart below the resistance at 35.14 EUR
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.